DOI: 10.1055/s-00034914

Osteologie

LinksSchließen

Referenz

Li X, Ominsky MS, Warmington KS. et al.
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;
24 (04) 578-588

Bibliographische Angaben herunterladen

Aufrufen in: